|Number of samples:||18|
|Release date:||Apr 1 2018|
|Last update date:||Nov 29 2018|
|Dataset link||MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block|
RNA-seq in 2 FN-RMS cell lines exposed to either DMSO or Trametinib treatment for various concentrations and timepoints, and siRNA against MEK1 or scramble.